More search options
Basket icon
No items
Basket icon

Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.

Abstract

EndoNav developed an innovative medical device to make colonoscopy procedures easier and faster to perform and less painful to receive. Despite of excellent technology, Internet protocol (IP) protection, a reasonably large market, and relatively low regulatory risk, the founder (Jaime Vargas) and his business partner (Kenneth Kelley, GSB MBA, 1987) are unable to secure venture funding. The company eventually decides that it must adapt its product and business plan so that it can be funded on a smaller scale by angel investors.
Location:
Silicon Valley
Industry:
Bio-technology, medical devices
Teaching note
-
Reference no. E214TN
Subject category: Entrepreneurship
Authors: Joshua Spitzer (Stanford Graduate School of Business, Stanford University)
Published by: Stanford Business School
Originally published in: 2006
Version: 8 September 2006
Length: 5 pages
Data source: Field research
View full details
Compact case
Supplement
-
Reference no. E214SQ
Subject category: Entrepreneurship
Authors: Joshua Spitzer (Stanford Graduate School of Business, Stanford University); Stefanos Zenios (Stanford Graduate School of Business, Stanford University)
Published by: Stanford Business School
Originally published in: 2006
Version: 3 May 2006
Length: 1 pages
Data source: Field research
Topics: Angel financing; Biotechnology; Business plans; Entrepreneurial finance; Entrepreneurship; Equity capital; New product marketing; Venture capital; Product-market fit
Notes: For terms & conditions go to www.thecasecentre.org/freecaseterms
View full details

About

Abstract

EndoNav developed an innovative medical device to make colonoscopy procedures easier and faster to perform and less painful to receive. Despite of excellent technology, Internet protocol (IP) protection, a reasonably large market, and relatively low regulatory risk, the founder (Jaime Vargas) and his business partner (Kenneth Kelley, GSB MBA, 1987) are unable to secure venture funding. The company eventually decides that it must adapt its product and business plan so that it can be funded on a smaller scale by angel investors.

Settings

Location:
Silicon Valley
Industry:
Bio-technology, medical devices

Related

Teaching note
-
Reference no. E214TN
Subject category: Entrepreneurship
Authors: Joshua Spitzer (Stanford Graduate School of Business, Stanford University)
Published by: Stanford Business School
Originally published in: 2006
Version: 8 September 2006
Length: 5 pages
Data source: Field research
View full details
Compact case
Supplement
-
Reference no. E214SQ
Subject category: Entrepreneurship
Authors: Joshua Spitzer (Stanford Graduate School of Business, Stanford University); Stefanos Zenios (Stanford Graduate School of Business, Stanford University)
Published by: Stanford Business School
Originally published in: 2006
Version: 3 May 2006
Length: 1 pages
Data source: Field research
Topics: Angel financing; Biotechnology; Business plans; Entrepreneurial finance; Entrepreneurship; Equity capital; New product marketing; Venture capital; Product-market fit
Notes: For terms & conditions go to www.thecasecentre.org/freecaseterms
View full details